English
简体中文
Total: £ 56.28
Published Date: 2025-02-07 | Pages: 78 | Tables: 86 | Medical Devices & Consumables
The global market for Breast Minimally Invasive Biopsy Needle was valued at US$ 29.1 million in the year 2024 and is projected to reach a revised size of US$ 39.2 million by 2031, growing at a CAGR of 3.1% during the forecast period.
A breast minimally invasive biopsy needle, often referred to as a vacuum-assisted biopsy (VAB) or core biopsy needle, is a specialized instrument used to obtain tissue samples from the breast for diagnostic purposes. Unlike traditional surgical biopsies, this procedure is minimally invasive, performed through a small incision in the skin. The needle, typically guided by ultrasound or mammography, uses a rotating cutting mechanism and vacuum suction to collect multiple tissue samples with a single insertion. This allows for a larger tissue sample compared to fine-needle aspiration, improving diagnostic accuracy, especially for microcalcifications or small lesions.
The breast minimally invasive biopsy needle industry is driven by several key trends focused on enhancing precision, patient comfort, and procedural efficiency. A primary trend is the development of smaller gauge needles and improved cutting mechanisms, minimizing patient discomfort and scarring while maintaining adequate tissue sample size. There is also a growing emphasis on real-time imaging integration, with some systems incorporating ultrasound transducers directly into the biopsy device, allowing for more precise targeting and reducing the risk of missing the lesion. Furthermore, manufacturers are focusing on enhancing the ergonomic design of the devices, making them easier for clinicians to handle and control, leading to improved procedural efficiency and reduced procedure time. Another trend is the development of automated or semi-automated biopsy systems that streamline the tissue collection process, further improving efficiency and consistency. Additionally, research is ongoing into developing needles with integrated markers or clips that can be deployed at the biopsy site, aiding in future localization for surgical removal if necessary. The use of advanced materials, such as biocompatible coatings and shape-memory alloys, is also being explored to improve needle performance and patient safety. These trends collectively aim to improve diagnostic accuracy, minimize patient trauma, and streamline the biopsy procedure for both clinicians and patients.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Breast Minimally Invasive Biopsy Needle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Minimally Invasive Biopsy Needle.
The Breast Minimally Invasive Biopsy Needle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Breast Minimally Invasive Biopsy Needle market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breast Minimally Invasive Biopsy Needle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Mammotome
Hologic
C.R Bard
BD
Stryker
Galini SRL
Medtronic
GMT Medical
Cultiva Medical
Zhejiang Jecan
Segment by Type
Needle Based Biopsy
Surgical Biopsy
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Breast Minimally Invasive Biopsy Needle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Breast Minimally Invasive Biopsy Needle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Breast Minimally Invasive Biopsy Needle Market Overview
1.1 Product Definition
1.2 Breast Minimally Invasive Biopsy Needle by Type
1.2.1 Global Breast Minimally Invasive Biopsy Needle Market Value Comparison by Type (2024 VS 2031)
1.2.2 Needle Based Biopsy
1.2.3 Surgical Biopsy
1.3 Breast Minimally Invasive Biopsy Needle by Application
1.3.1 Global Breast Minimally Invasive Biopsy Needle Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Breast Minimally Invasive Biopsy Needle Market Size Estimates and Forecasts
1.4.1 Global Breast Minimally Invasive Biopsy Needle Revenue 2020-2031
1.4.2 Global Breast Minimally Invasive Biopsy Needle Sales 2020-2031
1.4.3 Global Breast Minimally Invasive Biopsy Needle Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Breast Minimally Invasive Biopsy Needle Market Competition by Manufacturers
2.1 Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Manufacturers (2020-2025)
2.2 Global Breast Minimally Invasive Biopsy Needle Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Breast Minimally Invasive Biopsy Needle Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Breast Minimally Invasive Biopsy Needle, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Breast Minimally Invasive Biopsy Needle, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Breast Minimally Invasive Biopsy Needle, Product Type & Application
2.7 Global Key Manufacturers of Breast Minimally Invasive Biopsy Needle, Date of Enter into This Industry
2.8 Global Breast Minimally Invasive Biopsy Needle Market Competitive Situation and Trends
2.8.1 Global Breast Minimally Invasive Biopsy Needle Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Breast Minimally Invasive Biopsy Needle Players Market Share by Revenue
2.8.3 Global Breast Minimally Invasive Biopsy Needle Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Breast Minimally Invasive Biopsy Needle Market Scenario by Region
3.1 Global Breast Minimally Invasive Biopsy Needle Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Breast Minimally Invasive Biopsy Needle Sales by Region: 2020-2031
3.2.1 Global Breast Minimally Invasive Biopsy Needle Sales by Region: 2020-2025
3.2.2 Global Breast Minimally Invasive Biopsy Needle Sales by Region: 2026-2031
3.3 Global Breast Minimally Invasive Biopsy Needle Revenue by Region: 2020-2031
3.3.1 Global Breast Minimally Invasive Biopsy Needle Revenue by Region: 2020-2025
3.3.2 Global Breast Minimally Invasive Biopsy Needle Revenue by Region: 2026-2031
3.4 North America Breast Minimally Invasive Biopsy Needle Market Facts & Figures by Country
3.4.1 North America Breast Minimally Invasive Biopsy Needle Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Breast Minimally Invasive Biopsy Needle Sales by Country (2020-2031)
3.4.3 North America Breast Minimally Invasive Biopsy Needle Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Breast Minimally Invasive Biopsy Needle Market Facts & Figures by Country
3.5.1 Europe Breast Minimally Invasive Biopsy Needle Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Breast Minimally Invasive Biopsy Needle Sales by Country (2020-2031)
3.5.3 Europe Breast Minimally Invasive Biopsy Needle Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Breast Minimally Invasive Biopsy Needle Market Facts & Figures by Region
3.6.1 Asia Pacific Breast Minimally Invasive Biopsy Needle Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Breast Minimally Invasive Biopsy Needle Sales by Region (2020-2031)
3.6.3 Asia Pacific Breast Minimally Invasive Biopsy Needle Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Breast Minimally Invasive Biopsy Needle Market Facts & Figures by Country
3.7.1 Latin America Breast Minimally Invasive Biopsy Needle Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Breast Minimally Invasive Biopsy Needle Sales by Country (2020-2031)
3.7.3 Latin America Breast Minimally Invasive Biopsy Needle Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Breast Minimally Invasive Biopsy Needle Market Facts & Figures by Country
3.8.1 Middle East and Africa Breast Minimally Invasive Biopsy Needle Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Breast Minimally Invasive Biopsy Needle Sales by Country (2020-2031)
3.8.3 Middle East and Africa Breast Minimally Invasive Biopsy Needle Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Breast Minimally Invasive Biopsy Needle Sales by Type (2020-2031)
4.1.1 Global Breast Minimally Invasive Biopsy Needle Sales by Type (2020-2025)
4.1.2 Global Breast Minimally Invasive Biopsy Needle Sales by Type (2026-2031)
4.1.3 Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Type (2020-2031)
4.2 Global Breast Minimally Invasive Biopsy Needle Revenue by Type (2020-2031)
4.2.1 Global Breast Minimally Invasive Biopsy Needle Revenue by Type (2020-2025)
4.2.2 Global Breast Minimally Invasive Biopsy Needle Revenue by Type (2026-2031)
4.2.3 Global Breast Minimally Invasive Biopsy Needle Revenue Market Share by Type (2020-2031)
4.3 Global Breast Minimally Invasive Biopsy Needle Price by Type (2020-2031)
5 Segment by Application
5.1 Global Breast Minimally Invasive Biopsy Needle Sales by Application (2020-2031)
5.1.1 Global Breast Minimally Invasive Biopsy Needle Sales by Application (2020-2025)
5.1.2 Global Breast Minimally Invasive Biopsy Needle Sales by Application (2026-2031)
5.1.3 Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Application (2020-2031)
5.2 Global Breast Minimally Invasive Biopsy Needle Revenue by Application (2020-2031)
5.2.1 Global Breast Minimally Invasive Biopsy Needle Revenue by Application (2020-2025)
5.2.2 Global Breast Minimally Invasive Biopsy Needle Revenue by Application (2026-2031)
5.2.3 Global Breast Minimally Invasive Biopsy Needle Revenue Market Share by Application (2020-2031)
5.3 Global Breast Minimally Invasive Biopsy Needle Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mammotome
6.1.1 Mammotome Company Information
6.1.2 Mammotome Description and Business Overview
6.1.3 Mammotome Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mammotome Breast Minimally Invasive Biopsy Needle Product Portfolio
6.1.5 Mammotome Recent Developments/Updates
6.2 Hologic
6.2.1 Hologic Company Information
6.2.2 Hologic Description and Business Overview
6.2.3 Hologic Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hologic Breast Minimally Invasive Biopsy Needle Product Portfolio
6.2.5 Hologic Recent Developments/Updates
6.3 C.R Bard
6.3.1 C.R Bard Company Information
6.3.2 C.R Bard Description and Business Overview
6.3.3 C.R Bard Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.3.4 C.R Bard Breast Minimally Invasive Biopsy Needle Product Portfolio
6.3.5 C.R Bard Recent Developments/Updates
6.4 BD
6.4.1 BD Company Information
6.4.2 BD Description and Business Overview
6.4.3 BD Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BD Breast Minimally Invasive Biopsy Needle Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Stryker
6.5.1 Stryker Company Information
6.5.2 Stryker Description and Business Overview
6.5.3 Stryker Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Stryker Breast Minimally Invasive Biopsy Needle Product Portfolio
6.5.5 Stryker Recent Developments/Updates
6.6 Galini SRL
6.6.1 Galini SRL Company Information
6.6.2 Galini SRL Description and Business Overview
6.6.3 Galini SRL Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Galini SRL Breast Minimally Invasive Biopsy Needle Product Portfolio
6.6.5 Galini SRL Recent Developments/Updates
6.7 Medtronic
6.7.1 Medtronic Company Information
6.7.2 Medtronic Description and Business Overview
6.7.3 Medtronic Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Medtronic Breast Minimally Invasive Biopsy Needle Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 GMT Medical
6.8.1 GMT Medical Company Information
6.8.2 GMT Medical Description and Business Overview
6.8.3 GMT Medical Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GMT Medical Breast Minimally Invasive Biopsy Needle Product Portfolio
6.8.5 GMT Medical Recent Developments/Updates
6.9 Cultiva Medical
6.9.1 Cultiva Medical Company Information
6.9.2 Cultiva Medical Description and Business Overview
6.9.3 Cultiva Medical Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cultiva Medical Breast Minimally Invasive Biopsy Needle Product Portfolio
6.9.5 Cultiva Medical Recent Developments/Updates
6.10 Zhejiang Jecan
6.10.1 Zhejiang Jecan Company Information
6.10.2 Zhejiang Jecan Description and Business Overview
6.10.3 Zhejiang Jecan Breast Minimally Invasive Biopsy Needle Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zhejiang Jecan Breast Minimally Invasive Biopsy Needle Product Portfolio
6.10.5 Zhejiang Jecan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Breast Minimally Invasive Biopsy Needle Industry Chain Analysis
7.2 Breast Minimally Invasive Biopsy Needle Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Breast Minimally Invasive Biopsy Needle Production Mode & Process Analysis
7.4 Breast Minimally Invasive Biopsy Needle Sales and Marketing
7.4.1 Breast Minimally Invasive Biopsy Needle Sales Channels
7.4.2 Breast Minimally Invasive Biopsy Needle Distributors
7.5 Breast Minimally Invasive Biopsy Needle Customer Analysis
8 Breast Minimally Invasive Biopsy Needle Market Dynamics
8.1 Breast Minimally Invasive Biopsy Needle Industry Trends
8.2 Breast Minimally Invasive Biopsy Needle Market Drivers
8.3 Breast Minimally Invasive Biopsy Needle Market Challenges
8.4 Breast Minimally Invasive Biopsy Needle Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Breast Minimally Invasive Biopsy Needle Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Breast Minimally Invasive Biopsy Needle Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Breast Minimally Invasive Biopsy Needle Market Competitive Situation by Manufacturers in 2024
Table 4. Global Breast Minimally Invasive Biopsy Needle Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Breast Minimally Invasive Biopsy Needle Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Breast Minimally Invasive Biopsy Needle Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Breast Minimally Invasive Biopsy Needle Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Breast Minimally Invasive Biopsy Needle, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Breast Minimally Invasive Biopsy Needle, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Breast Minimally Invasive Biopsy Needle, Product Type & Application
Table 12. Global Key Manufacturers of Breast Minimally Invasive Biopsy Needle, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Breast Minimally Invasive Biopsy Needle by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Minimally Invasive Biopsy Needle as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Breast Minimally Invasive Biopsy Needle Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Breast Minimally Invasive Biopsy Needle Sales by Region (2020-2025) & (K Units)
Table 18. Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Region (2020-2025)
Table 19. Global Breast Minimally Invasive Biopsy Needle Sales by Region (2026-2031) & (K Units)
Table 20. Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Region (2026-2031)
Table 21. Global Breast Minimally Invasive Biopsy Needle Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Breast Minimally Invasive Biopsy Needle Revenue Market Share by Region (2020-2025)
Table 23. Global Breast Minimally Invasive Biopsy Needle Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Breast Minimally Invasive Biopsy Needle Revenue Market Share by Region (2026-2031)
Table 25. North America Breast Minimally Invasive Biopsy Needle Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Breast Minimally Invasive Biopsy Needle Sales by Country (2020-2025) & (K Units)
Table 27. North America Breast Minimally Invasive Biopsy Needle Sales by Country (2026-2031) & (K Units)
Table 28. North America Breast Minimally Invasive Biopsy Needle Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Breast Minimally Invasive Biopsy Needle Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Breast Minimally Invasive Biopsy Needle Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Breast Minimally Invasive Biopsy Needle Sales by Country (2020-2025) & (K Units)
Table 32. Europe Breast Minimally Invasive Biopsy Needle Sales by Country (2026-2031) & (K Units)
Table 33. Europe Breast Minimally Invasive Biopsy Needle Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Breast Minimally Invasive Biopsy Needle Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Breast Minimally Invasive Biopsy Needle Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Breast Minimally Invasive Biopsy Needle Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Breast Minimally Invasive Biopsy Needle Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Breast Minimally Invasive Biopsy Needle Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Breast Minimally Invasive Biopsy Needle Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Breast Minimally Invasive Biopsy Needle Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Breast Minimally Invasive Biopsy Needle Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Breast Minimally Invasive Biopsy Needle Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Breast Minimally Invasive Biopsy Needle Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Breast Minimally Invasive Biopsy Needle Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Breast Minimally Invasive Biopsy Needle Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Breast Minimally Invasive Biopsy Needle Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Breast Minimally Invasive Biopsy Needle Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Breast Minimally Invasive Biopsy Needle Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Breast Minimally Invasive Biopsy Needle Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Breast Minimally Invasive Biopsy Needle Sales (K Units) by Type (2020-2025)
Table 51. Global Breast Minimally Invasive Biopsy Needle Sales (K Units) by Type (2026-2031)
Table 52. Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Type (2020-2025)
Table 53. Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Type (2026-2031)
Table 54. Global Breast Minimally Invasive Biopsy Needle Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Breast Minimally Invasive Biopsy Needle Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Breast Minimally Invasive Biopsy Needle Revenue Market Share by Type (2020-2025)
Table 57. Global Breast Minimally Invasive Biopsy Needle Revenue Market Share by Type (2026-2031)
Table 58. Global Breast Minimally Invasive Biopsy Needle Price (US$/Unit) by Type (2020-2025)
Table 59. Global Breast Minimally Invasive Biopsy Needle Price (US$/Unit) by Type (2026-2031)
Table 60. Global Breast Minimally Invasive Biopsy Needle Sales (K Units) by Application (2020-2025)
Table 61. Global Breast Minimally Invasive Biopsy Needle Sales (K Units) by Application (2026-2031)
Table 62. Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Application (2020-2025)
Table 63. Global Breast Minimally Invasive Biopsy Needle Sales Market Share by Application (2026-2031)
Table 64. Global Breast Minimally Invasive Biopsy Needle Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Breast Minimally Invasive Biopsy Needle Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Breast Minimally Invasive Biopsy Needle Revenue Market Share by Application (2020-2025)
Table 67. Global Breast Minimally Invasive Biopsy Needle Revenue Market Share by Application (2026-2031)
Table 68. Global Breast Minimally Invasive Biopsy Needle Price (US$/Unit) by Application (2020-2025)
Table 69. Global Breast Minimally Invasive Biopsy Needle Price (US$/Unit) by Application (2026-2031)
Table 70. Mammotome Company Information
Table 71. Mammotome Description and Business Overview
Table 72. Mammotome Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Mammotome Breast Minimally Invasive Biopsy Needle Product
Table 74. Mammotome Recent Developments/Updates
Table 75. Hologic Company Information
Table 76. Hologic Description and Business Overview
Table 77. Hologic Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Hologic Breast Minimally Invasive Biopsy Needle Product
Table 79. Hologic Recent Developments/Updates
Table 80. C.R Bard Company Information
Table 81. C.R Bard Description and Business Overview
Table 82. C.R Bard Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. C.R Bard Breast Minimally Invasive Biopsy Needle Product
Table 84. C.R Bard Recent Developments/Updates
Table 85. BD Company Information
Table 86. BD Description and Business Overview
Table 87. BD Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. BD Breast Minimally Invasive Biopsy Needle Product
Table 89. BD Recent Developments/Updates
Table 90. Stryker Company Information
Table 91. Stryker Description and Business Overview
Table 92. Stryker Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Stryker Breast Minimally Invasive Biopsy Needle Product
Table 94. Stryker Recent Developments/Updates
Table 95. Galini SRL Company Information
Table 96. Galini SRL Description and Business Overview
Table 97. Galini SRL Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Galini SRL Breast Minimally Invasive Biopsy Needle Product
Table 99. Galini SRL Recent Developments/Updates
Table 100. Medtronic Company Information
Table 101. Medtronic Description and Business Overview
Table 102. Medtronic Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Medtronic Breast Minimally Invasive Biopsy Needle Product
Table 104. Medtronic Recent Developments/Updates
Table 105. GMT Medical Company Information
Table 106. GMT Medical Description and Business Overview
Table 107. GMT Medical Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. GMT Medical Breast Minimally Invasive Biopsy Needle Product
Table 109. GMT Medical Recent Developments/Updates
Table 110. Cultiva Medical Company Information
Table 111. Cultiva Medical Description and Business Overview
Table 112. Cultiva Medical Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cultiva Medical Breast Minimally Invasive Biopsy Needle Product
Table 114. Cultiva Medical Recent Developments/Updates
Table 115. Zhejiang Jecan Company Information
Table 116. Zhejiang Jecan Description and Business Overview
Table 117. Zhejiang Jecan Breast Minimally Invasive Biopsy Needle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Zhejiang Jecan Breast Minimally Invasive Biopsy Needle Product
Table 119. Zhejiang Jecan Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Breast Minimally Invasive Biopsy Needle Distributors List
Table 123. Breast Minimally Invasive Biopsy Needle Customers List
Table 124. Breast Minimally Invasive Biopsy Needle Market Trends
Table 125. Breast Minimally Invasive Biopsy Needle Market Drivers
Table 126. Breast Minimally Invasive Biopsy Needle Market Challenges
Table 127. Breast Minimally Invasive Biopsy Needle Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Breast Minimally Invasive Biopsy Needle
Figure 2. Global Breast Minimally Invasive Biopsy Needle Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Breast Minimally Invasive Biopsy Needle Market Share by Type: 2024 & 2031
Figure 4. Needle Based Biopsy Product Picture
Figure 5. Surgical Biopsy Product Picture
Figure 6. Global Breast Minimally Invasive Biopsy Needle Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Breast Minimally Invasive Biopsy Needle Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Breast Minimally Invasive Biopsy Needle Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Breast Minimally Invasive Biopsy Needle Market Size (2020-2031) & (US$ Million)
Figure 12. Global Breast Minimally Invasive Biopsy Needle Sales (2020-2031) & (K Units)
Figure 13. Global Breast Minimally Invasive Biopsy Needle Average Price (US$/Unit) & (2020-2031)
Figure 14. Breast Minimally Invasive Biopsy Needle Report Years Considered
Figure 15. Breast Minimally Invasive Biopsy Needle Sales Share by Manufacturers in 2024
Figure 16. Global Breast Minimally Invasive Biopsy Needle Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Breast Minimally Invasive Biopsy Needle Players: Market Share by Revenue in Breast Minimally Invasive Biopsy Needle in 2024
Figure 18. Breast Minimally Invasive Biopsy Needle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Breast Minimally Invasive Biopsy Needle Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Breast Minimally Invasive Biopsy Needle Sales Market Share by Country (2020-2031)
Figure 21. North America Breast Minimally Invasive Biopsy Needle Revenue Market Share by Country (2020-2031)
Figure 22. United States Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Breast Minimally Invasive Biopsy Needle Sales Market Share by Country (2020-2031)
Figure 25. Europe Breast Minimally Invasive Biopsy Needle Revenue Market Share by Country (2020-2031)
Figure 26. Germany Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Breast Minimally Invasive Biopsy Needle Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Breast Minimally Invasive Biopsy Needle Revenue Market Share by Region (2020-2031)
Figure 33. China Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Breast Minimally Invasive Biopsy Needle Sales Market Share by Country (2020-2031)
Figure 41. Latin America Breast Minimally Invasive Biopsy Needle Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Colombia Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Breast Minimally Invasive Biopsy Needle Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Breast Minimally Invasive Biopsy Needle Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Breast Minimally Invasive Biopsy Needle Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Breast Minimally Invasive Biopsy Needle by Type (2020-2031)
Figure 52. Global Revenue Market Share of Breast Minimally Invasive Biopsy Needle by Type (2020-2031)
Figure 53. Global Breast Minimally Invasive Biopsy Needle Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Breast Minimally Invasive Biopsy Needle by Application (2020-2031)
Figure 55. Global Revenue Market Share of Breast Minimally Invasive Biopsy Needle by Application (2020-2031)
Figure 56. Global Breast Minimally Invasive Biopsy Needle Price (US$/Unit) by Application (2020-2031)
Figure 57. Breast Minimally Invasive Biopsy Needle Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
